A study published in the journal Anesthesiology shows that opioids in a patient's body can enhance the malignant tendencies of cancer cells, regardless of further opioids being added, according to News & Research Outcomes Magazine.
The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton's findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Attention Anesthesiologists: CMS Guidelines on Signatures and Check Boxes
Anesthesia Machine Sales Expected to Pick Up in 2014
Heritage Valley Names Dr. Brett Anderson Chair of Anesthesiology
The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton's findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Attention Anesthesiologists: CMS Guidelines on Signatures and Check Boxes
Anesthesia Machine Sales Expected to Pick Up in 2014
Heritage Valley Names Dr. Brett Anderson Chair of Anesthesiology